SCHEMBL6911343

SCHEMBL6911343

CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)CCc1cccc(S(=O)(=O)NC(C)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.45
MMP1 P03956 5/20 0.44
MMP3 P08254 1/20 0.44
CTSL P07711 2/20 0.43
PTPN1 P18031 1/20 0.42
BCL2 P10415 2/20 0.41
FCER2 P06734 1/20 0.41
PLAT P00750 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP2 P08253 3/20 0.40
MMP9 P14780 3/20 0.40
MMP8 P22894 3/20 0.40
MMP13 P45452 2/20 0.40
ITGB3 P05106 1/20 0.40
ITGAV P06756 1/20 0.40
CA2 P00918 1/20 0.39
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911348 1.00 L3MBTL1 (0.45) L3MBTL1MMP1MMP3CTSLPTPN1
SCHEMBL6917602 0.85 PTPRB (0.46) L3MBTL1PTPN1PLATMEN1KMT2A
SCHEMBL6917607 0.85 PTPRB (0.46) L3MBTL1PTPN1PLATMEN1KMT2A
SCHEMBL6803191 0.83 MEN1 (0.55) MMP1MMP3CTSLPTPN1FCER2
SCHEMBL6803737 0.83 MEN1 (0.55) MMP1MMP3CTSLPTPN1FCER2
SCHEMBL6803202 0.83 MEN1 (0.55) MMP1MMP3CTSLPTPN1FCER2
SCHEMBL6911344 0.79 L3MBTL1 (0.41) L3MBTL1MMP1MEN1KMT2AMMP2
SCHEMBL4457674 0.79 MMP1 (0.52) MMP1MMP3CTSLFCER2MEN1
SCHEMBL6911352 0.76 L3MBTL1 (0.42) L3MBTL1MMP1KMT2AMMP2MMP9
SCHEMBL6828040 0.74 MEN1 (0.70) L3MBTL1MMP1MMP3CTSLPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE L3MBTL1 3997/4885MMP1 857/4885MMP3 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.